Pseudomonas aeruginosa strains from nosocomial pneumonia are more serum resistant than P. aeruginosa strains from noninfectious respiratory colonization processes

Infection

Volumn 33, Issue 5-6, 2005, Pages 356-361

  Vitkauskiene, A ^a   Scheuss S ^b   Sakalauskas, R ^a   Dudzevicius, V ^a   Sahly, H ^b  

^a KAUNAS UNIVERSITY OF MEDICINE   (Lithuania)

^b UNIVERSITY OF KIEL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BACTERIAL COLONIZATION; BACTERIAL PNEUMONIA; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERIUM ISOLATE; BLOOD GROUP A; BLOOD GROUP B; BLOOD GROUP O; BLOOD GROUP TYPING; CONTROLLED STUDY; HOSPITAL INFECTION; HUMAN; INTENSIVE CARE UNIT; LUNG ASPIRATION; LUNG LAVAGE; MAJOR CLINICAL STUDY; NONHUMAN; PSEUDOMONAS AERUGINOSA; RESPIRATORY TRACT INFECTION; SEROPREVALENCE;

BLOOD BACTERICIDAL ACTIVITY; BRONCHOALVEOLAR LAVAGE FLUID; CROSS INFECTION; HUMANS; INTENSIVE CARE UNITS; O ANTIGENS; PNEUMONIA, BACTERIAL; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; SEROTYPING;

EID: 27644491471     PISSN: 03008126     EISSN: None     Source Type: Journal    
DOI: 10.1007/s15010-005-5044-x     Document Type: Article

References (36)

1. Hauser AR, Sriram P: Severe Pseudomonas aeruginosa infections. Tackling the conundrum of drug resistance. Postgrad Med 2005; 117: 41-48.
2. Pier GB, Ramphal R: Pseudomonas aeruginosa. In: Mandel GL, Bennet JE, Dolin R (eds): Mandell, Douglas and Bennet's principles and practice of infectious diseases (6th edn). Churchill Livingstone, New York 2005, pp 2587-2615.
3. Spencer RC: Predominant pathogens found in the European Prevalence of Infection in Intensive Care Study. Eur J Clin Microbiol Infect Dis 1996; 15: 281-285.
4. Harbarth S, Ruef C, Francioli P, Widmer A, Pittet D: Nosocomial infections in Swiss university hospitals: a multi-centre survey and review of the published experience. Swiss-Noso Network. Schweiz Med Wochenschr 1999; 129: 1521-1528.
5. Weber DJ, Raasch R, Rutala WA: Nosocomial infections in the ICU: the growing importance of antibiotic-resistant pathogens. Chest 1999; 115 (Suppl. 3): 34-41.
6. Vincent JL: Nosocomial infections in adult intensive-care units. Lancet 2003; 361: 2068-2077.
7. Chastre J, Fagon JY: Ventilator-associated pneumonia. Am J Respir Crit Care Med 2002; 165: 867-903.
8. Garau J, Gomez L: Pseudomonas aeruginosa pneumonia. Curr Opin Infect Dis 2003; 16: 135-143.
9. Reyes MP, El-Khatib MR, Brown WJ, Smith F, Lerner AM: Synergy between carbenicillin and an aminoglycoside (gentamicin or tobramycin) against Pseudomonas aeruginosa isolated from patients with endocarditis and sensitivity of isolates to normal human serum. J Infect Dis 1979; 140: 192-202.
10. Schiller NL, Millard RL: Pseudomonas-infected cystic fibrosis patient sputum inhibits the bactericidal activity of normal human serum. Pediatr Res 1983; 17: 747-752.
11. Young LS, Armstrong D: Human immunity to Pseudomonas aeruginosa. In-vitro interaction of bacteria, polymorphonuclear leukocytes, and serum factors. J Infect Dis 1972; 126: 257-276.
12. Hancock RE, Mutharia LM, Chan L, Darveau RP, Speert DP, Pier GB: Pseudomonas aeruginosa isolates from patients with cystic fibrosis: a class of serum-sensitive, nontypable strains deficient in lipopolysaccharide O side chains. Infect Immun 1983; 42: 170-177.
13. Pier GB, Ames P: Mediation of the killing of rough, mucoid isolates of Pseudomonas aeruginosa from patients with cystic fibrosis by the alternative pathway of complement. J Infect Dis 1984; 150: 223-228.
14. Cryz SJ Jr, Pitt TL, Furer E, Germanier R: Role of lipopolysaccharide in virulence of Pseudomonas aeruginosa. Infect Immun 1984; 44: 508-513.
15. Dasgupta T, de Kievit TR, Masoud H, Altman E, Richards JC, Sadovskaya I, Speert DP, Lam JS: Characterization of lipopolysaccharide-deficient mutants of Pseudomonas aeruginosa derived from serotypes O3,O5, and O6. Infect Immun 1994; 62: 809-817.
16. Porat R, Johns MA, McCabe WR: Selective pressures and lipopolysaccharide subunits as determinants of resistance of clinical isolates of gram-negative bacilli to human serum. Infect Immun 1987; 55: 320-328.
17. Rocchetta HL, Burrows LL, Lam JS: Genetics of O-antigen biosynthesis in Pseudomonas aeruginosa. Microbiol Mol Biol Rev 1999; 63: 523-553.
18. CDC. NNIS criteria for determining nosocomial pneumonia. Atlanta, GA: US Department of Health and Human Services, CDC, 2003.
19. Homma JY: Designation of the thirteen O-group antigens of Pseudomonas aeruginosa: an amendment for the tentative proposal in 1976. Jpn J Exp Med 1982; 52: 317-320.
20. Podschun R, Sievers D, Fischer A, Ullmann U: Serotypes, hemagglutinins, siderophore synthesis, and serum resistance of Klebsiella isolates causing human urinary tract infections J Infect Dis 1993; 168: 1415-1421.
21. Sahly H, Aucken H, Benedi VJ, Forestier C, Fussing V, Hansen DS, Ofek I, Podschun R, Sirot D, Tomás JM, Ullmann U: Increased serum-resistance properties in Klebsiella pneumoniae strains producing extended spectrum β-lactamases. Antimicrob Agents Chemother 2004; 48: 3477-3482.
22. Oiling S: Sensitivity of gram-negative bacilli to the serum bactericidal activity: a marker of the host parasite relationship in acute and persisting infections. Scand J Infect Dis 1977; 10: 1-40.
23. Schoolnik GK, Buchanan TM, Holmes KK: Gonococci causing disseminated gonococcal infection are resistant to the bactericidal action of normal human sera. J Clin Invest 1976; 58: 1163-1173.
24. Simberkoff MS, Ricupero I, Rahal JJJ: Host resistance to Serratia marcescens infection: serum bactericidal activity and phagocytosis by normal blood leucocytes. J Lab Clin Med 1976; 87: 206-217.
25. Preston MJ, Fleiszig SM, Zaidi TS, Goldberg JB, Shortridge VD, Vasil ML, Pier GB: Rapid and sensitive method for evaluating Pseudomonas aeruginosa virulence factors during corneal infections in mice. Infect Immun 1995; 63: 3497-501.
26. Tang HB, DiMango E, Bryan R, Gambello M, Iglewski BH, Goldberg JB, Prince A.: Contribution of specific Pseudomonas aeruginosa virulence factors to pathogenesis of pneumonia in a neonatal mouse model of infection. Infect Immun 1996; 64: 37-43.
27. Campbell WN, Hendrix E, Cryz S Jr, Cross AS: Immunogenicity of a 24-valent Klebsiella capsular polysaccharide vaccine and an eight-valent Pseudomonas 0-polysaccharide conjugate vaccine administered to victims of acute trauma. Clin Infect Dis 1996; 23: 179-181.
28. Podschun R, Penner I, Ullmann U: Interaction of Klebsiella capsule type 7 with human polymorphonuclear leucocytes. Microb Pathog 1992; 13: 371-379.
29. Athamna A, Ofek I, Keisari Y, Markowitz S, Dutton GGS, Sharon N: Lectinophagocytosis of encapsulated Klebsiella pneumoniae mediated by surface lectin of guinea pig alveolar macrophages and human monocyte-derived macrophages. Infect Immun 1991; 59: 1673-1682.
30. Kabha K, Schmegner J, Keisari Y, Parolis H, Schlepper-Schaeffer J, Ofek I: SP-A enhances phagocytosis of Klebsiella by interaction with capsular polysaccharides and alveolar macrophages. Am J Physiol 1997; 272: 344-352.
31. Keisari Y, Wang H, Mesika A, Matatov R, Nissimov L, Crouch E, Ofek I: Surfactant protein D-coated Klebsiella pneumoniae stimulates cytokine production in mononuclear phagocytes. J Leukoc Biol 2001; 70: 135-141.
32. Ofek I, Mesika A, Kalina M, Keisari Y, Podschun R, Sahly H, Chang D, McGregor D, Crouch E: Surfactant protein D (SP-D) enhances the phagocytosis and killing of unencapsulated phase variants of Klebsiella pneumoniae. Infect Immun 2001; 69: 24-33.
33. Sahly H, Ofek I, Podschun R, Brade H, He Y, Crouch E: Surfactant protein D binds selectively to Klebsiella pneumoniae lipopolysaccharides containing mannose-rich antigens. J Immunol 2002; 169: 3267-3274.
34. Mariencheck WI, Savov J, Dong Q, Tino MJ, Wright JR: Surfactant protein A enhances alveolar macrophage phagocytosis of a live, mucoid strain of P. aeruginosa. Am J Physiol 1999; 277: 777-786.
35. Restrepo CI, Dong Q, Savov J, Mariencheck Wl, Wright JR: Surfactant protein D stimulates phagocytosis of Pseudomonas aeruginosa by alveolar macrophages. Am J Respir Cell Mol Biol 1999; 21: 576-585.
36. Bufler P, Schmidt B, Schikor D, Bauernfeind A, Crouch EC, Griese M: Surfactant protein A and D differently regulate the immune response to nonmucoid Pseudomonas aeruginosa and its lipopolysaccharide. Am J Respir Cell Mol Biol 2003; 28: 249-256.